Optimvia
PrivateLast Round
Seed
Apr 8, 2026
Total Funding Raised
$523,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Optimvia is a biopharmaceutical company that has developed a biosynthetic manufacturing process designed for engineering enzymes and their cofactors to synthesize complex therapeutic molecules like heparin.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optimvia Comparables
Compare Optimvia with similar companies based on industry and business-model similarity.
No public comparables are available for Optimvia. Request access to learn about comparables coverage.
Request accessOptimvia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 8, 2026 | ||||
| Seed | Aug 29, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 569% MoM.
- May 15, 2026
Monthly visitors increased 142% MoM.
Optimvia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Optimvia's valuation, stock price, and market status.
Is Optimvia a public or private company?
Optimvia is a private company.
What is the current stock price of Optimvia?
Optimvia is a private company, so its shares have no public market price. Caplight tracks Optimvia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Optimvia worth (valuation)?
Valuation information for Optimvia is not publicly available.
Can I buy Optimvia stock?
Optimvia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Optimvia's last funding round?
Optimvia's most recent funding round was Seed on April 8, 2026.
Who are the main investors in Optimvia?
Investor information for Optimvia is not publicly disclosed.
Will Optimvia IPO soon?
No public IPO plans have been announced for Optimvia.
How can I track Optimvia secondary market activity?
Caplight tracks bids, offers, and trades in Optimvia's shares on secondary markets.